Back

Worldwide incidence, management and outcome of systemic embolism following atrial fibrillation ablation: preliminary results from the EMBOL-AF registry.

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: clinical / stroke Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sergio Castrejon Castrejon

La Paz University Hospital, Madrid (Spain)

11 More presentations in this session

Presentation thumbnail
Discussant review - EMBOL-AF
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Discussion - EMBOL-AF
Video
Presentation thumbnail
3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial
Doctor R. Galea (Bern, CH)
Slides Video
Presentation thumbnail
Discussant review - SWISS-APERO
Professor O. wazni (Cleveland, US)
Video
Presentation thumbnail
Discussion - SWISS-APERO
Video

Access the full session

Session thumbnail
Late-Breaking Science: clinical / stroke
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Comparing cerebral microembolisation patterns between high power short duration and pulsed field ablation techniques using artificial intelligence based robotic transcranial doppler monitoring
thumbnail
Congress Presentation
Discussant review - EMBOL-AF
thumbnail
Congress Session
Complications in atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources